Month: March 2012

Coordinate the fight against TB and HIV saves the life of 900,000 people

|

MADRID, 02 (EUROPA PRESS) The World Health Organization (who) has released this Friday an update of its Guide to the prevention, diagnosis and treatment of tuberculosis and HIV. The objective is to “provide continuity to the success” reached with the first in 2004, that improving collaboration between the services of attention to both diseases has saved the lives of approximately 910.000 people in just six years. New lines of who to diagnose, prevent and treat HIV and tuberculosis together detailing on Monday, March 5, at the Conference on infections of Retroviruses and opportunistic (CROI, in English), in Seattle, Washington. To give continuity to the success achieved with the first guide on tuberculosis and HIV, launched in 2004, who has today released an update of its overall policy to prevent, diagnose and treat together the TB and HIV, reported from the who, they recalled that TB is “the leading cause of death for people with HIV”. Since 2004, has increased up to 12 times the number of people with HIV who has been testing to detect tuberculosis, from 200,000 people analyzed in 2005 to 2.3 million people in 2010. Also, evidence of HIV among TB patients have increased about five times, from 470,000 tests 2005 to 2.2 million in 2010. With the experience accumulated in the last six years, who now launches an update of these guidelines to accelerate the...

Read More
PSN signed a collaboration agreement with Tenerife dentists.

PSN signed a collaboration agreement with Tenerife dentists.

|

PSN signed a collaboration agreement with Tenerife dentists. the school has also signed a collective accidents policy. Madrid, March 2012.- forecast national (PSN) has signed a collaboration agreement with the College of dentists in Santa Cruz de Tenerife. Thus, more than 500 members will have access under preferential conditions to the broad portfolio of products and services of PSN: safe protection personal and family wealth management, consulting on data protection for dental clinics, nursery schools and residences for the elderly, among others. in addition to the signing of this agreement, the Professional Corporation has relied on PSN to protect...

Read More

Two new studies presented at the XXVII Congress annual of the European Association of Urology (EAU) show that degarelix, to reduce the prostatic volume in patients with advanced hormonodependiente prostate cancer, is not less than the set

|

Two new studies presented at the XXVII Congress annual of the European Association of Urology (EAU) show that degarelix, to reduce the prostatic volume in patients with advanced hormonodependiente prostate cancer, is not less than the combination of goserelin with bicalutamida. -prostate cancer is the most common male cancer in the Western world. Each year are diagnosed around 300,000 new cases of prostate cancer in Europe and worldwide 670.000 -prostate cancer depends on testosterone for growth and to reduce levels of testosterone slows down the growth of cancer cells -Degarelix has unique chemical characteristics and mechanism of action novel, unlike conventional hormonal therapies; rapidly reduces testosterone levels within a period of three days without using an antiandrogen to avoid the flare Madrid, March 2012.- two new studies presented at the XXVII Congress annual of the European Association of Urology (EAU) which was held in Paris have shown that degarelixa blocker of the recipients of the releasing hormone gonadotropin (GnRH) to reduce total prostatic volume in men with advanced hormonodependiente prostate cancer, is similar to the combination of goserelin (a GnRH agonist) with bicalutamida. Degarelix, marketed under the name of Firmagon ® offers also a better control of the lower urinary tract symptoms (LOOTZ)(1-2). The LOOTZ can be frequency, urgency and urinary difficulty, and affect negatively the quality of life (3-4) for men with prostate cancer. Prostate cancer is the...

Read More

Hospital Universitario de La Ribera participates in the national rare diseases survey coordinated by the prestigious biomedical research in Network Center.

|

El Hospital Universitario de La Ribera participates in the national rare diseases survey coordinated by the prestigious biomedical research in Network Center. yesterday was held the day world of the disease rare. -experts consider strange those pathologies of very low prevalence – 5 cases per 10,000 population – and has an incomplete understanding regarding their diagnosis, its evolution and its treatment – according to experts9 out of 10 cases with a rare disease are caused by an alteration of the chromosomes or unknown genetic mutations Alzira, March 2012.- El Hospital Universitario de La Ribera is currently engaged in the national study on birth defects or malformations coordinated by the prestigious Centre of biomedical research in network (CIBERER)an entity of the Instituto de Salud Carlos III. The objective of this programme, called the research on the clínico-etiológicos aspects of children born with malformations and other birth defects is to establish a register of newborns with defects that deepen in the classification and management of rare diseases. Precisely, yesterday held the world day for rare diseases. As a member of this platform for research, which involves other hospitals of Spain, La Ribera is one of the health centres responsible for collecting and registering all clinical and genetic information of cases. To do so, the Paediatrics Service of the hospital of Alzira studied in each case more than 250 items related to...

Read More

Experts point out that the biological therapies are the most effective treatment in rheumatoid arthritis.

|

Experts point out that the biological therapies are the most effective treatment in rheumatoid arthritis. in the multidisciplinary meeting in Zafra under the title: optimization in the management of biological therapies ”. -Rheumatoid arthritis is a disease severe and disabling from the point of view physical and work that affects approximately one percent of the adult population worldwide, mostly women (i) – according to experts, some of the existing biological therapies show a lower immunogenicity, which can lead to significant clinical and economic consequences – day data from the study have been PRESERVED, the first study conducted exclusively in patients with active moderate rheumatoid arthritis where it is shown that a high percentage of patients in treatment with etanercept reach remission clinical and radiological Zafra, March 2012.- immunogenicity, aspects farmacoenómicos and cost-effectiveness of different biological therapies, as well as the results of the study may PRESERVE, they have been the topics covered during the multidisciplinary meeting in Zafra, under the title: optimization of biological therapy ”. The day has counted with the support of the biomedical company Pfizer, and has brought together rheumatologists and immunologists of Extremadura. According to doctor José Luis Álvarez Vega, Hospital Infanta Cristina de Badajoz rheumatologist and coordinator of the day: this meeting has enabled us to deepen the knowledge of specific aspects of biological therapy, which is the Group of more effective drugs in...

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips